Optometric Management Magazine

It is a case we see far too commonly in our postoperative refractive surgery visits: a patient who presents a few months post-op, still feeling like they are on a rollercoaster of fluctuating vision and looking to you for answers. Dry eye disease (DED) does not typically begin as a postoperative complication. In most cases, especially for the age range of our cataract surgery patients, it is a preoperative condition—one that surgery likely did not create but absolutely amplifies.

Earlier this year, Glaukos commercially launched the first FDA-approved, noninvasive, epithelium-on corneal cross-linking treatment for keratoconus. Epioxa HD/Epioxa is a topical therapy that is catalyzed by enriched oxygen and light, and is designed to reduce the pain associated with corneal epithelium removal, streamline the procedure, and minimize recovery.

Welcome to The Coding Corner, a space where doctors who are already excellent at doctoring can dig into the finer details of coding, documentation, compliance, and the occasional mystery that is the AMA Evaluation and Management (E/M) grid. Each month, Tonya Reynoldson, OD, brings forward real-world coding questions we commonly hear in eyecare practices, and she and Sarah Haney break them down from both clinical and coding perspectives.

Symptoms of dry eye disease (DED) are a leading cause of visits to eyecare providers and affect hundreds of millions of people globally. Treating and managing patients with DED pose a significant challenge for eyecare providers because it is a complex multifactorial disease that comprises many different etiological factors. Many dry eye patients have seen multiple doctors over several years without any relief from their symptoms and their symptoms often continue to worsen.

Prevent Blindness has designated July as Dry Eye Month as part of an effort to raise awareness about dry eye disease, offering a variety of free educational resources eyecare professionals can share with their patients—including a dedicated webpage, fact sheets, social media graphics in English and Spanish, and videos featuring experts and patients. As part of this year’s campaign, Prevent Blindness will feature a discussion on dry eye in a July episode of its Focus on Eye Health Podcast.

Newton announced in a press release the expansion of its Sequel lens line to include Sequel Computer and Sequel Meeting, both of which feature proprietary Convergence Boost technology. Both lenses are available through VSP, along with the full Sequel portfolio of lenses. According to the company, Sequel Computer is designed for heavy computer users who spend hours each day in front of their laptop or desktop.

Hi, everyone. Great to be here. My name is Dr. Masoud Nafey, and I'm here to talk to you a little bit about the most common AI models or large language models. These are platforms that you can use either for free or use the pro versions for roughly $20 a month. That’s pretty much the standard fee for all these models. With the pro versions, you will get faster processing power, the latest and greatest models, and more functionality.

New pharmaceutical agents, sustained-release delivery systems, biologic therapies, and presbyopia treatments are moving the ophthalmic therapeutic market toward mechanism-based treatment selection, reduced preservative exposure, and delivery platforms that are designed to improve adherence and reduce treatment burden, said Mitch Ibach, OD, FAAO, and Jake Lang, OD, FAAO, in their “Drops, Drugs, and Delivery: What’s New in Ophthalmic Therapeutics” presentation at Optometry’s Meeting 2026 in...

Harvey Richman, OD, and Rebecca H. Wartman, OD In their presentation at Optometry's Meeting 2026 in Phoenix, Rebecca H. Wartman, OD, and Harvey Richman, OD, highlighted how optometrists can incorporate remote monitoring into their practice and shared new codes and guidance for the appropriate use of remote physiological monitoring (RPM) and remote therapeutic monitoring (RTM).

Hormonal changes during perimenopause and menopause affect far more than reproductive health—they can have significant implications for ocular surface disease, glaucoma risk, retinal health, and overall visual function.